Page 54 - Compliance Program News Today

The Bioresearch Monitoring Program (BIMO), run by the U.S. Food and Drug Administration (FDA), oversees the conduct of on-site inspections and data audits of FDA-regulated research in support of new product development and marketing approvals.

Partner Amy Schuh will speak on a joint Ethisphere/Lextegrity webinar, “Lessons from the Trenches: Developing a Compliance Program to Meet Regulator Expectations.”

We provide herein the executive summary of 19 newly enacted regulations in Indonesia issued between February and April 2022.

In the June 3 issue of Employee Plans News, the Internal Revenue Service announced a pilot program to give employers whose qualified retirement plans have been selected for audit a...

Accounting Services, Trust and Corporate Formation, or Management Consulting Services are now off limits to Russian Nationals as per the May 8, 2022 U.S. Department of the Treasury’s...

Commissioner Rebecca F. Dye of the Federal Maritime Commission (FMC or the Commission) has released her Final Report for Fact Finding 29 titled "The Effects of COVID-19 on the U.S. International Ocean Transportation Supply Chain."

SANTIAGO (Reuters) - Chile's environmental regulator initiated a sanction process against Antofagasta Minerals' Los Pelambres copper mine for deficien...

Sanction for deficiencies associated with tailings management, Chile's environmental regulator said.

Even though the Form ADV Annual Updating Amendment (“AUA”) is in the rearview mirror, advisors must stay on top of changes in their firm, as well as regulatory updates, that could...

In this episode of the Compliance Week 2022 Preview Podcasts series, Andy Powell will discuss some of his presentations at Compliance Week 2022, "Introducing Interactivity and...